Recro to Present at Oppenheimer Fall Healthcare Life Sciences & Medtech Summit
September 18 2020 - 7:30AM
Recro (Nasdaq:REPH), a leading contract development and
manufacturing organization (CDMO), with integrated solutions for
the development, formulation, regulatory support, manufacturing and
packaging of oral solid dose drug products, today announced that
Gerri Henwood, the Company’s President and Chief Executive Officer,
will present at the Oppenheimer Fall Healthcare Life Sciences &
Medtech Summit on Tuesday, September 22, 2020 at 4:10 p.m. ET.
A live webcast of the presentation will be
available on the “Presentations” page within the Investors section
of the Recro website at https://ir.recropharma.com. A replay will
be available on the Recro website for a period of 30 days following
the event.
About Recro
Recro is a contract development and
manufacturing, or CDMO, business, with integrated solutions for the
development, formulation, manufacturing and CTM management of high
potency and other solid oral dose forms and located in
Gainesville, GA. The Company leverages its formulation expertise to
develop and manufacture pharmaceutical products using its
proprietary delivery technologies and other manufacturing services
for commercial and development-stage partners who commercialize or
plan to commercialize these products. For more information see
www.recropharma.com.
Contacts
Investor Relations Contact: Argot Partners Sam Martin / Claudia
Styslinger (212) 600-1902 sam@argotpartners.com
Claudia@argotpartners.com
Recro Ryan D. Lake (484) 395-2436 rlake@recropharma.com
Media Contact: Argot Partners David Rosen (212) 600-1902
David.rosen@argotpartners.com
Recro Pharma (NASDAQ:REPH)
Historical Stock Chart
From Apr 2024 to May 2024
Recro Pharma (NASDAQ:REPH)
Historical Stock Chart
From May 2023 to May 2024